{
  "id": 4308,
  "text": "# Methods The guideline has been developed according to the WHO handbook for guideline development, second edition (2014).The Guideline Development Group (GDG) for this guideline was formed in early 2019 and, based on their clinical expertise, research and knowledge of tests in development, identified 13 clinical algorithms (involving several different screening tests) for screening and treatment that could be evaluated.",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: # Methods The guideline has been developed according to the WHO handbook for guideline development, second edition (2014).The Guideline Development Group (GDG) for this guideline was formed in early 2019 and, based on their clinical expertise, research and knowledge of tests in development, identified 13 clinical algorithms (involving several different screening tests) for screening and treatment \n\n<question>: \n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n",
  "ChatGPT_response_0": "SKIP.",
  "query": "根据您提供的内容，这段文字似乎没有与宫颈癌明确相关的信息。因此，根据指令，我的回答是：SKIP。",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 根据您提供的内容，这段文字似乎没有与宫颈癌明确相关的信息。因此，根据指令，我的回答是：SKIP。\n\n<reference text>: # Methods The guideline has been developed according to the WHO handbook for guideline development, second edition (2014).The Guideline Development Group (GDG) for this guideline was formed in early 2019 and, based on their clinical expertise, research and knowledge of tests in development, identified 13 clinical algorithms (involving several different screening tests) for screening and treatment that could be evaluated.\n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n\n<reply>: ",
  "response": "SKIP."
}